πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,720 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7951817

Pyridomorphinans, pyridazinomorphinans and use thereof

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7951383

Attenuated parainfluenza virus (PIV) vaccines

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7947289

Multimeric protein toxins to target cells having multiple identifying characteristics

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue May 24 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 19 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7947651

Secreted frizzled related protein, sFRP, fragments and methods of use thereof

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 24 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 19 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7947822

HIV vaccines based on Env of multiple clades of HIV

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 24 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 19 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7943159

Female sex pheromone of the dogwood borer (DWB), Synanthedon scitula, and attraction inhib

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue May 17 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7943148

Amino acid sites in Flavivirus E proteins useful for development of diagnostics and vaccin

The United States of America as represented by the Secretary of the Army Β· Granted Tue May 17 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7943775

Small molecules for imaging protein-protein interactions

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue May 17 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7943318

Microrna-based methods and compositions for the diagnosis, prognosis and treatment of lung

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue May 17 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7939639

Functional role of adrenomedullin (AM) and the gene related product (PAMP) in human pathol

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 10 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 05 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7939635

Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 10 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 05 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7935351

Use of CPG oligodeoxynucleotides to induce angiogenesis

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 03 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7932096

Trioxyethylene gold nanoclusters functionalized with a single DNA

United States of America as represented by the Secretary of the Air Force Β· Granted Tue Apr 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7932074

Multivalent human-bovine rotavirus vaccine

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Apr 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7931919

Method of producing glycine-stabilized, lyophilized plasma

The United States of America as represented by the Secretary of the Army Β· Granted Tue Apr 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7928096

Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related c

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7927793

Cell lines and host nucleic acid sequences related to infectious disease

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7928079

Polysaccharide-derived nitric oxide-releasing carbon-bound diazeniumdiolates

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7928194

Recombinant antigen for diagnosis and prevention of murine typhus

United States of America as represented by the Secretary of the Air Force Β· Granted Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7923535

Tryptophan as a functional replacement for ADP-ribose-arginine in recombinant proteins

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Apr 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7919104

Functional epitopes of Streptococcus pneumoniae PsaA antigen and uses thereof

The United States of America as represtented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7919607

Nucleic acids encoding humanized anti-tag 72 CC49 antbodies

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7919477

Multiple CpG oligodeoxynucleotides and their use to induce an immune response

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7919301

Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from CDNA and use of reco

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted